1. Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 1995;102(2):101–6.

2. Tita AT, Landon MB, Spong CY, Lai Y, Leveno KJ, Varner MW, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009;360(2):111–20.

3. Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008;336(7635):85–7.

4. Bentley JP, Burgner DP, Shand AW, Bell JC, Miller JE, Nassar N. Gestation at birth, mode of birth, infant feeding and childhood hospitalization with infection. Acta Obstet Gynecol Scand 2018 May 16 [Epub ahead of print].

5. Dong Y, Chen SJ, Yu JL. A systematic review and meta-analysis of long-term development of early term infants. Neonatology 2012;102(3):212–21.

6. Searle AK, Smithers LG, Chittleborough CR, Gregory TA, Lynch JW. Gestational age and school achievement: a population study. Arch Dis Child Fetal Neonatal Ed 2017;102(5):F409–F16.

7. Bentley JP, Roberts CL, Bowen JR, Martin AJ, Morris JM, Nassar N. Planned birth before 39 weeks and child development: a population-based study. Pediatrics 2016;138(6).

8. Murray SR, Shenkin SD, McIntosh K, Lim J, Grove B, Pell JP, et al. Long term cognitive outcomes of early term (37–38 weeks) and late preterm (34–36 weeks) births: a systematic review. Wellcome Open Res 2017;2:101.

9. Organisation for Economic Co-operation and Development. Health at a glance 2017: OECD indicators. Figure 6.5. Paris: OECD Publishing; 2017.

10. NPS MedicineWise. Antibiotic resistance in Australia: here and now [Internet]. Sydney: NPS MedicineWise; 2016. Available from: https://www.nps.org.au/news/antibiotic-resistance-in-australia-here-and-now

11. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.

12. Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Turner S, Devereux G, et al. Early life antibiotic use and the risk of asthma and asthma exacerbations in children. Pediatr Allergy Immunol 2017;28(5):430–7.

13. Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr 2018:e180315.

14. Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Respir J 2011;38(2):295–302.

15. Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol 2018;53(1):1–7.

16. Ungaro R, Bernstein C, Gearry R, Hviid A, Kolho K, Kronman M, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 2014;109(11):1728–38.

17. Bell JC, Schneuer FJ, Harrison C, Trevena L, Hiscock H, Elshaug AG, et al. Acid suppressants for managing gastro-oesophageal reflux and gastro‑oesophageal reflux disease in infants: a national survey. Arch Dis Child 2018;103(7):660–4.

18. Kirby CN, Segal AY, Hinds R, Jones KM, Piterman L. Infant gastro-oesophageal reflux disease (GORD): Australian GP attitudes and practices. J Paediatr Child Health 2016;52(1):47–53.

19. Gieruszczak-Białek D, Konarska Z, Skórka A, Vandenplas Y, Szajewska H. No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials. J Pediatr 2015;166(3):767–70.

20. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117(5):e817–20.

21. Trikha A, Baillargeon JG, Kuo YF, Tan A, Pierson K, Sharma G, et al. Development of food allergies in patients with gastroesophageal reflux disease treated with gastric acid suppressive medications. Pediatr Allergy Immunol 2013;24(6):582–8.

22. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report 2018. Canberra: AIHW; 2018. (AIHW Cat. No. CAN 112.)

23. Gastroenterological Society of Australia. Information about gastroscopy. Melbourne: Digestive Health Foundation; 2012. http://cart.gesa.org.au/membes/ files/Consumer%20Information/Gastroscopy_A4.pdf (accessed Aug 2018).

24. Better Health Channel. Upper GI endoscopy [Internet]. Melbourne: State Government of Victoria; 2015 [updated 2015 Jun 29; cited 2018 Aug 10]. Available from: www3.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/pages/E01lite_en

25. National Health Service (UK). Overview: gastroscopy [Internet]. London: NHS; 2018 [updated 2018 Jun 12; cited 2018 Aug 10]. Available from: https://www.nhs.uk/conditions/gastroscopy/

26. Medicare Australia Statistics. Medicare items 30473, 30476, 30478 processed from July 2006 to June 2017 per capita [Internet]. Canberra: Medicare Australia; 2018 [cited 2018 Mar].
Available from: http://medicarestatistics.humanservices.gov.au/statistics/mbs_item.jsp

27. Australian Institute of Health and Welfare. Cancer in Australia 2017. Canberra: AIHW; 2017. (AIHW Cat. No. CAN 100; Cancer Series No. 101.)

28. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000;25(5):333–40.

29. Hughes JD, Tanpurekul W, Keen NC, Ee HC. Reducing the cost of proton pump inhibitors by adopting best practice. Qual Prim Care 2009;17(1):15–21.

30. Naunton M, Peterson GM, Deeks LS, Young H, Kosari S. We have had a gutful: the need for deprescribing proton pump inhibitors. J Clin Pharm Ther 2018;43(1):65–72.

31. NPS MedicineWise. Proton pump inhibitors: too much of a good thing? [Internet]. Sydney: NPS MedicineWise; 2015 [cited 2017 Dec 19].
Available from: https://www.nps.org.au/medical-info/clinical-topics/news/proton-pump-inhibitors-too-much-of-a-good-thing

32. Scarpignato C, Gatta L, Zullo A, Blandizzi C. Effective and safe proton pump inhibitor therapy in acid-related diseases: a position paper addressing benefits and potential harms of acid suppression. BMC Medicine 2016;14(1):179.

33. Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 2017;152:706–15.

34. Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut 2016;65(5):740–8.

35. Medicare Benefits Schedule Review Taskforce. First report from the pathology clinical committee: endocrine tests. Canberra: Australian Government Department of Health; 2017.

36. Australian Institute of Health and Welfare. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2011. Canberra: AIHW; 2016. (AIHW Cat. No. BOD 4; Australian Burden of Disease Study Series No. 3.)